Bruker (BRKR) PT Lowered to $69 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $56.50 --0%
Rating Summary:
14 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Rating Summary:
14 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Join SI Premium – FREE
Barclays analyst Luke Sergott lowered the price target on Bruker (NASDAQ: BRKR) to $69.00 (from $75.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Bruker (BRKR) Tops Q3 EPS by 14c; offers guidance
- Westpac Banking Corp. (WBC:AU) (WBK) PT Lowered to AUD41.50 at UBS
- Astera Labs (ALAB) PT Lowered to $300 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
